metastatic

Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line treatment for metastatic kidney cancer

By Sharon Deveson Kell|2025-08-06T14:34:18+00:006 Aug 2025|Drug treatments|

Treatment of advanced (metastatic) kidney cancer has improved considerably over [...]

Comments Off

Lenvatinib plus everolimus for patients with metastatic kidney cancer

By Sharon Deveson Kell|2024-04-22T14:43:56+00:0022 Apr 2024|Uncategorized|

The treatment of heavily pretreated patients with metastatic kidney cancer [...]

Comments Off

Belzutifan for advanced kidney cancer: long-term follow-up

By Sharon Deveson Kell|2024-11-21T09:24:59+00:0030 Nov 2023|Drug treatments|

Studies looking at the genes of people with kidney cancer have shown [...]

Comments Off

Real world treatment of advanced kidney cancer

By Sharon Deveson Kell|2023-11-10T08:34:23+00:0010 Nov 2023|Drug treatments|

Nearly 30% of new kidney cancer cases are diagnosed at [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Our Website Design Specialist | Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org